<DOC>
	<DOC>NCT02758496</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).</brief_summary>
	<brief_title>A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD</brief_title>
	<detailed_description>This is a retrospective chart review of 200 consecutive charts of subjects ages 2-20 years old seen at the Brain Treatment Center between 2010 and 2015. The review is designed to evaluate the safety and efficacy of Magnetic Electroencephalogram/Electrocardiogram(EEG/ECG)-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>1. Must have completed a baseline EEG at the Brain Treatment Center (BTC) 2. Age between 2 and 20 years old at initial visit 3. Must have a diagnosis of ASD according to the prevailing standard at that time (i.e., Diagnostic and Statistical ManualIV (DSMIV)) (ASD Group only) 4. Must have received Magnetic EEG/ECGGuided Resonance Therapy (MeRT) for more than (5) sessions (ASD Group only) 5. Clinically significant abnormality or clinically significant unstable medical condition during treatment that in the Investigator's judgment may have may limited interpretation of the results.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Autism, chart review, transcranial magnetic stimulation (TMS)</keyword>
</DOC>